Molecular Partners Ag股价上涨10.10% 市值涨132.73万美元

自选股智能写手03-19

北京时间2024年03月19日01时41分，Molecular Partners Ag（MOLN.us）股票出现异动，股价急速拉升10.10%。截至发稿，该股报4.36美元/股，成交量419股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入7.83百万美元，净利润-68.97百万美元，每股收益-2.10美元，毛利--，市盈率-1.77倍。机构评级方面，在所有4家参与评级的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2420283809?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-19 01:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2420283809","market":"us","top_or_hot":-1,"title":"Molecular Partners Ag股价上涨10.10% 市值涨132.73万美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年03月19日01时41分，Molecular Partners Ag（MOLN.us）股票出现异动，股价急速拉升10.10%。截至发稿，该股报4.36美元/股，成交量419股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入7.83百万美元，净利润-68.97百万美元，每股收益-2.10美元，毛利--，市盈率-1.77倍。机构评级方面，在所有4家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031901415387e79d15&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Molecular Partners Ag股价上涨10.10% 市值涨132.73万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMolecular Partners Ag股价上涨10.10% 市值涨132.73万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-19 01:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031901415387e79d15&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年03月19日01时41分，Molecular Partners Ag（MOLN.us）股票出现异动，股价急速拉升10.10%。截至发稿，该股报4.36美元/股，成交量419股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入7.83百万美元，净利润-68.97百万美元，每股收益-2.10美元，毛利--，市盈率-1.77倍。机构评级方面，在所有4家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031901415387e79d15&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4563","symbol_name":"昨日强势股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031901415387e79d15&s=b","article_id":"2420283809","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031901415387e79d15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2420283809","pubTimestamp":1710783713,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年03月19日01时41分，Molecular Partners Ag股票出现异动，股价急速拉升10.10%。截至发稿，该股报4.36美元/股，成交量419股，换手率0.00%，振幅0.00%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.43%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发称为 DARPin 疗法的蛋白质疗法，用于治疗严重疾病，包括癌症和威胁视力的疾病。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4563":"昨日强势股","IMRX":"Immuneering Corp","BK4139":"生物科技","BK4539":"次新股","MOLN":"Molecular Partners AG"},"translate_title":"Molecular Partners Ag rose 10.10 percent to $1,327,300","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MOLN":0.9,"IMRX":0.81},"content_text":"北京时间2024年03月19日01时41分，Molecular Partners Ag（MOLN.us）股票出现异动，股价急速拉升10.10%。截至发稿，该股报4.36美元/股，成交量419股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入7.83百万美元，净利润-68.97百万美元，每股收益-2.10美元，毛利--，市盈率-1.77倍。机构评级方面，在所有4家参与评级的机构中，25%的券商给予买入建议，50%的券商给予持有建议，25%的券商给予卖出建议。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Artelo Biosciences Inc C/Wts 20/06/2024 (To Pur Com)、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 (To Pur Com)、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)涨幅较大，Zyversa Therapeutics, Inc.、Immuneering Corporation、Jaguar Health, Inc.较为活跃，换手率分别为142.67%、43.35%、30.86%，振幅较大的相关个股有Artelo Biosciences Inc C/Wts 20/06/2024 (To Pur Com)、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 (To Pur Com)、Immuneering Corporation，振幅分别为443.52%、71.48%、67.02%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。 该公司专注于一类新型生物制药产品的发现、开发和预期商业化。 该公司开发称为 DARPin 疗法的蛋白质疗法，用于治疗严重疾病，包括癌症和威胁视力的疾病。 该公司的产品线主要通过三个领域进行组织：眼科，包括针对湿性年龄相关性黄斑变性和糖尿病性黄斑水肿等视网膜疾病的疗法； 肿瘤学管道包括具有新作用模式的 DARPin 候选物，包括多 DARPin 化合物以及用于抗癌治疗的免疫肿瘤学。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2420283809"}